The Medicines Company (MDCO) Shares Bought by Legal & General Group Plc

Share on StockTwits

Legal & General Group Plc boosted its position in shares of The Medicines Company (NASDAQ:MDCO) by 3.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 159,914 shares of the company’s stock after purchasing an additional 5,835 shares during the period. Legal & General Group Plc’s holdings in The Medicines were worth $3,050,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Vanguard Group Inc boosted its holdings in The Medicines by 2.5% during the 3rd quarter. Vanguard Group Inc now owns 6,681,573 shares of the company’s stock valued at $199,846,000 after acquiring an additional 162,702 shares during the period. Vanguard Group Inc. boosted its holdings in The Medicines by 2.5% during the 3rd quarter. Vanguard Group Inc. now owns 6,681,573 shares of the company’s stock valued at $199,846,000 after acquiring an additional 162,702 shares during the period. Westfield Capital Management Co. LP boosted its holdings in The Medicines by 21.6% during the 4th quarter. Westfield Capital Management Co. LP now owns 4,604,719 shares of the company’s stock valued at $88,134,000 after acquiring an additional 817,508 shares during the period. Iridian Asset Management LLC CT boosted its holdings in The Medicines by 75.4% during the 4th quarter. Iridian Asset Management LLC CT now owns 3,296,816 shares of the company’s stock valued at $63,101,000 after acquiring an additional 1,417,229 shares during the period. Finally, Elk Creek Partners LLC boosted its holdings in The Medicines by 28.4% during the 4th quarter. Elk Creek Partners LLC now owns 763,154 shares of the company’s stock valued at $14,607,000 after acquiring an additional 168,802 shares during the period.

Shares of MDCO opened at $28.19 on Tuesday. The Medicines Company has a 1 year low of $16.69 and a 1 year high of $41.57.

The Medicines (NASDAQ:MDCO) last announced its quarterly earnings data on Wednesday, February 27th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.58) by ($0.09). During the same quarter last year, the firm posted ($0.61) earnings per share. As a group, equities analysts predict that The Medicines Company will post -2.51 EPS for the current fiscal year.

MDCO has been the subject of a number of research analyst reports. Zacks Investment Research cut The Medicines from a “hold” rating to a “sell” rating in a report on Wednesday, December 19th. BidaskClub upgraded The Medicines from a “sell” rating to a “hold” rating in a report on Saturday, February 2nd. Roth Capital initiated coverage on The Medicines in a report on Thursday, March 21st. They set a “buy” rating and a $75.00 target price for the company. Finally, Robert W. Baird initiated coverage on The Medicines in a report on Wednesday, March 27th. They set an “outperform” rating and a $80.00 target price for the company. Three analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The Medicines currently has a consensus rating of “Buy” and a consensus price target of $53.13.

In related news, Director Alexander J. Denner acquired 248,100 shares of the firm’s stock in a transaction dated Wednesday, March 6th. The stock was acquired at an average price of $24.91 per share, for a total transaction of $6,180,171.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Alexander J. Denner acquired 325,000 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was bought at an average price of $25.45 per share, with a total value of $8,271,250.00. The disclosure for this purchase can be found here. Insiders bought a total of 673,100 shares of company stock valued at $16,966,421 in the last quarter. Company insiders own 10.29% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally published by Zolmax and is owned by of Zolmax. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://zolmax.com/investing/the-medicines-company-mdco-shares-bought-by-legal-general-group-plc/3038698.html.

About The Medicines

The Medicines Company, a biopharmaceutical company, provides medicines to treat acute and intensive care patients. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for patients undergoing percutaneous coronary intervention in the United States.

Further Reading: How Does the Quiet Period Work?

Want to see what other hedge funds are holding MDCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Medicines Company (NASDAQ:MDCO).

Institutional Ownership by Quarter for The Medicines (NASDAQ:MDCO)

Receive News & Ratings for The Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Medicines and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nimiq Achieves Market Capitalization of $6.62 Million
Nimiq Achieves Market Capitalization of $6.62 Million
WeAreSatoshi Tops 24-Hour Volume of $0.00
WeAreSatoshi Tops 24-Hour Volume of $0.00
Everex  Market Cap Reaches $16.35 Million
Everex Market Cap Reaches $16.35 Million
Versant Capital Management Inc Buys 106 Shares of Netflix, Inc.
Versant Capital Management Inc Buys 106 Shares of Netflix, Inc.
Versant Capital Management Inc Reduces Holdings in Vanguard Large-Cap ETF
Versant Capital Management Inc Reduces Holdings in Vanguard Large-Cap ETF
Versant Capital Management Inc Sells 146 Shares of Valero Energy Co.
Versant Capital Management Inc Sells 146 Shares of Valero Energy Co.


 
© 2006-2019 Zolmax.